FRANKFURT: Pfizer and BioNTech’s COVID-19 vaccine has been given to 140,000 people in Britain, and the feedback on side effects and tolerability has been reassuring, BioNTech’s chief medical officer said on Thursday.
Britain was the first to approve the shot for emergency use on Dec. 3, followed by Canada and the US Food and Drug Administration.
“In Britain, 140,000 people have been vaccinated by now and the tolerability data are exactly as we have shown in our clinical trial,” Chief Medical Officer Oezlem Tuereci said in a webcast call with German Chancellor Angela Merkel.
She said side effects have been mild to moderate and short-lived and similar to those typically seen in other commonly used vaccines.
The German biotech firm’s Chief Executive Ugur Sahin said in the call that he was confident that normal life could resume by next winter.
UK’s vaccine approval raises world’s hopes for COVID-19 fight UK authorizes Pfizer coronavirus vaccine for emergency use
Was the ‘American cheetah’ a cheetah at all? 
AI agents aren’t ready to replace humans in behavioral research 
A culprit for corrosion may have been operating under our noses 
New Hubble images reveal a bizarre decagon over Saturn’s south pole 
A massive study unveils the genetic underpinnings of fibromyalgia 
The universe may have been building rocky planets almost from the start 
Coordinated action on clean air and climate change can net $15 for every dollar spent 
Human rights chief Türk renews call for end to spiralling Sudan war 
AI: Türk urges action before it becomes an ‘existential risk to humanity’ 
UNGA 81: A United Nations at a Turning Point